Rife built microscopes and obtained a United States patent for his lamp.
Frequency Archive // Public Record Review
Royal Raymond Rife
Documented apparatus, recorded experiments, numerical results, and the missing evidence behind the best-known claims.
His strongest paper concerned filtered typhoid cultures, not healing.
The famous 1934 outcomes cannot be reconstructed from patient-level data.
Document Ledger
What Rife actually left in the record.
The archive mixes patents, journal papers, notebooks, correspondence, later interviews, and reports written by associates. They are not all equivalent forms of evidence.
Microscope lamp
- Research
- Adjustable illumination for conventional microscopes.
- Recorded data
- A ventilated, rheostat-controlled lamp mounted below the microscope stage to provide flat, uniform illumination.
- Evidence assessment
- A verifiable engineering achievement. The patent does not describe a cancer treatment or therapeutic frequency generator.
Filtered B. typhosus cultures
- Research
- Kendall and Rife examined repeatedly filtered bacterial cultures.
- Recorded data
- Three filtrations, reported 5,000x observation, eight repeated observations, and uninoculated K Medium controls. Motile turquoise bodies were reported.
- Evidence assessment
- A genuine preliminary journal communication. The authors inferred that the bodies were filterable bacterial forms; it was not a treatment or cancer study.
Rosenow microscope observations
- Research
- Filtered typhoid, streptococcal, poliomyelitis, and herpes preparations.
- Recorded data
- Objects were reported at 8,000x in selected filtrates; a normal rabbit-brain preparation was used as a negative comparison.
- Evidence assessment
- An independent published observation involving Rife's microscope. It did not test clinical treatment, survival, or healing outcomes.
BX organism and tumor notebooks
- Research
- Tumor material was cultured, filtered, and viewed microscopically.
- Recorded data
- One surviving rat note records a 60 g lipoma, tissue culture, Berkefeld filtration, and purple-red non-motile granules viewed at a reported 4,000x.
- Evidence assessment
- Fragmentary notebook evidence. No complete controlled series, blinded pathology review, survival table, or reproducible identification protocol survives.
La Jolla clinic claim
- Research
- A later account describes frequency-device treatment of 16 patients.
- Recorded data
- The often-repeated claim is 14 patients clinically cured after about 70 days and two later.
- Evidence assessment
- The patient-level records, diagnoses, settings, pathology, response criteria, and follow-up dataset are unavailable. This is not a recoverable clinical study.
The New Microscopes
- Research
- Seidel and Winter summarized Rife's microscope and laboratory claims.
- Recorded data
- The article reports more than 20,000 cultures, 426 inoculated rats, and BX-like particles in 92% of neoplastic cases.
- Evidence assessment
- These are narrative totals, not a published dataset. The article supplies no animal-level table, control allocation, pathology protocol, or statistical analysis.
Stafford electromagnetic-field report
- Research
- Rats, one dog, 16 terminal-cancer cases, and 16 dermatology cases.
- Recorded data
- The retrospective report contains the clearest surviving Rife-associated numerical treatment data, including a small leukemia-rat comparison.
- Evidence assessment
- Written by Robert Stafford, not Rife. The animal groups were incomplete and the human observations were uncontrolled case reports.
Recorded Protocol
The Stafford signal setup, 1957-1963.
This is historical apparatus documentation, not a treatment protocol. Stafford said the operating theory was presumptive and that the frequencies might be wrong or only nearly correct.
Numerical Record
The leukemia-rat experiment.
The report planned balanced groups but did not achieve them. These descriptive numbers are presented without converting them into an efficacy percentage.
Deaths occurred at 39, 43, and 49 days. All three were positive for chloroma at death.
Four deaths occurred at 46, 48, 53, and 55 days. The displayed mean covers those four deaths only.
One treated survivor was sacrificed and remained positive for transplantable leukemia.
Two were asymptomatic, but the author said inoculation may have failed or been rejected.
The paucity of data prevented a firm conclusion and further controlled experiments were needed.
Human Case Record
Sixteen terminal malignancies. No reported cure.
Stafford documented temporary pain relief, reduced bleeding, softening of some lesions, or brief functional improvement in selected cases. Several cases showed no appreciable benefit, and the diseases generally progressed.
Archive Verdict
Real apparatus. Preliminary observations. Unverified cures.
Rife's patent, instruments, and early microscopy collaborations are part of the historical record. The surviving treatment material does not contain the complete controls, patient records, blinded pathology, standardized outcomes, or independent replication required to verify the 1934 cancer claims.